Cargando…
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials
BACKGROUND: Adenosine administered as an adjunct to reperfusion can reduce coronary no-reflow and limit myocardial infarct (MI) size in ST-segment elevation myocardial infarction (STEMI) patients. Whether adjunctive adenosine therapy can improve clinical outcomes in reperfused STEMI patients is not...
Autores principales: | Bulluck, Heerajnarain, Sirker, Alex, Loke, Yoon K., Garcia-Dorado, David, Hausenloy, Derek J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669305/ https://www.ncbi.nlm.nih.gov/pubmed/26402450 http://dx.doi.org/10.1016/j.ijcard.2015.09.005 |
Ejemplares similares
-
Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping
por: Bulluck, Heerajnarain, et al.
Publicado: (2017) -
Diagnostic performance of T
(1) and T
(2) mapping to detect intramyocardial hemorrhage in reperfused ST‐segment elevation myocardial infarction (STEMI) patients
por: Bulluck, Heerajnarain, et al.
Publicado: (2017) -
Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial
por: Bulluck, Heerajnarain, et al.
Publicado: (2019) -
Redefining viability by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction
por: Bulluck, Heerajnarain, et al.
Publicado: (2017) -
Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment–Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)